1 of 1
HOUSE DOCKET, NO. 3177 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 2372
The Commonwealth of Massachusetts
_________________
PRESENTED BY:
Christine P. Barber
_________________
To the Honorable Senate and House of Representatives of the Commonwealth of Massachusetts in General
Court assembled:
The undersigned legislators and/or citizens respectfully petition for the adoption of the accompanying bill:
An Act relative to collaborative drug therapy management optimization.
_______________
PETITION OF:
NAME:DISTRICT/ADDRESS :DATE ADDED:Christine P. Barber34th Middlesex1/16/2025Patrick Joseph Kearney4th Plymouth2/3/2025 1 of 1
HOUSE DOCKET, NO. 3177 FILED ON: 1/16/2025
HOUSE . . . . . . . . . . . . . . . No. 2372
By Representative Barber of Somerville, a petition (accompanied by bill, House, No. 2372) of
Christine P. Barber and Patrick Joseph Kearney relative to collaborative drug therapy
management optimization. Public Health.
[SIMILAR MATTER FILED IN PREVIOUS SESSION
SEE HOUSE, NO. 2134 OF 2023-2024.]
The Commonwealth of Massachusetts
_______________
In the One Hundred and Ninety-Fourth General Court
(2025-2026)
_______________
An Act relative to collaborative drug therapy management optimization.
Be it enacted by the Senate and House of Representatives in General Court assembled, and by the authority
of the same, as follows:
1 Notwithstanding section 24 B1/2 of chapter 112 of the General Laws or any other general
2or special laws to the contrary, collaborative drug therapy management may be allowed in
3ambulatory care clinics licensed pursuant to section 51 of chapter 111 of the General Laws if: (i)
4there is on-site or off-site supervision by the attending physician and a collaborating pharmacist;
5and (ii) collaborative drug therapy management is approved by the ambulatory care clinic's
6medical staff executive committee or designee or medical director or designee.